Freshwater microalgae–bacteria consortia are increasingly used in wastewater treatment and biomass production, yet their bacterial partners may serve as reservoirs of multidrug-resistant (MDR) bacteria and antibiotic resistance genes (ARGs). In this...
Freshwater microalgae–bacteria consortia are increasingly used in wastewater treatment and biomass production, yet their bacterial partners may serve as reservoirs of multidrug-resistant (MDR) bacteria and antibiotic resistance genes (ARGs). In this study, we isolated three bacterial strains (Chryseobacterium sp. P1, Pseudomonas monteilii P2, and Stenotrophomonas pavanii P3) from the phycosphere of the freshwater microalga Pectinodesmus pectinatus and characterized their genomic and phenotypic traits related to antibiotic resistance. Whole-genome sequencing and comparative genomic analyses were combined with minimum inhibitory concentration (MIC) testing against 16 antibiotics. ARGs were predicted using multiple databases and mapped onto functional modules, including L-Ara4N/PEtN-mediated lipid A modification, lipopolysaccharide (LPS) biosynthesis and transport, efflux pumps, and putative two-component regulatory systems. All three isolates carried diverse ARGs and exhibited elevated MICs to several β-lactams; colistin MICs differed among isolates (≥16 μg/mL in Chryseobacterium sp. P1 and S. pavanii P3 vs ≤2 μg/mL in P. monteilii P2), and S. pavanii showed the broadest MDR phenotype. Consistent with this phenotype, it harbored the most extensive repertoire of genes associated with L- Ara4N/PEtN modification (e.g. arn family, eptA), LPS/outer-membrane maintenance, and multidrug efflux that have been implicated in, and may contribute to, colistin non- susceptibility. Qualitative genotype–phenotype concordance analysis across three bacterial isolates revealed that many resistance patterns could be explained by the presence or absence of known determinants. Overall, our results suggest that the P. pectinatus phycosphere can harbor MDR and colistin-non-susceptible Stenotrophomonas strains and underscore freshwater microalgae-based systems as potential environmental reservoirs of clinically relevant antibiotic resistance.